European panel gives nod to engineered knee-repair product

04/29/2013 | Medscape (free registration)

The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended Genzyme's matrix-induced autologous chondrocyte implantation for marketing approval. The knee-repair product uses a porcine collagen scaffold seeded with autologous cartilage cells. The European Commission will make the final decision.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA